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Abstract 
Purpose: To investigate the effect of total hydroalcohol root extract of Plumeria alba (Apocynaceae) 
and its active fraction on diabetes in rats.  
Methods: The effect of total hydroalcohol extract at 250 mg/kg and different fractions was evaluated on 
oral glucose tolerance test (OGTT) in mice. The effect of the active fractions on OGTT was measured 
on a model of diabetic rats (fructose-enriched fat diet and streptozotocin-induced). 
Results: The results show that the total extract (250 mg/kg), ethyl acetate fraction and supernatant 
fraction (obtained after centrifugation of total extract) at a dose of 100 mg/kg significantly (p < 0.01) 
reduced hyperglycemia induced by glucose overload in mice. Fructose-enriched fat diet increased blood 
cholesterol, triglycerides and high density lipoprotein (HDL) levels in hyperlipidemic untreated rats 
compared to normal control rats. Administration of total extract (250 mg/kg/day) and supernatant 
fraction of P. alba (100 mg/kg/day) during 14 days significantly reduced lipid parameters (total 
cholesterol, p < 0.001;   triglycerides, p < 0.01; HDL, p < 0.05). Analysis of oxidative stress markers 
shows that the  supernatant  fraction  and  total extract significantly increased serum glutathione level (p 
< 0.01) but significantly lowered malondialdehyde (MDA) concentration in liver (p < 0.05).  
Conclusion: These results suggest that the total extract and fractions of P. alba exhibit significant 
antidiabetic and hypolipidemic properties in streptozotocin-induced diabetic animals. The supernatant 
fraction (which is free of organic solvent) was the most biologically active  
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Diabetes mellitus (DM) is a chronic metabolic 
disorder caused by an absolute or relative lack 
of/or resistance to insulin and is characterized by 
hyperglycemia in the postprandial and/or fasting 
state [1]. Presently, it is estimated that 220 
million people worldwide have diabetes and this 
number will increase to 300 million on 2025. 
Globally, type-2 diabetes (non-insulin dependent 
diabetes mellitus) accounts more than ninety 
percent of all cases of diabetes is caused by a 
combination of resistance to insulin action and 
impaired insulin secretion, resulting glucose 
intolerance [2]. This metabolic disorder 
characterized by chronic hyperglycemia (fasting 
blood glucose ≥ 7 mmol/l) is known to be the 
major initiator of micro and macro vascular 
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complications in diabetics [3,4]. Therefore, 
control of postprandial plasma glucose levels is 
important in the early treatment of diabetes and 
reducing chronic vascular complications. 
 
Impaired glucose tolerance (IGT) is a risk factor 
for future diabetes and/or adverse outcomes. It is 
characterized by a moderate hyperglycemia 2 h 
post-load plasma-glucose that results from 
muscle insulin resistance and impaired insulin 
secretion [5]. The loss of early insulin secretion in 
IGT and type 2 diabetes is the result of 
malfunctioning of the pancreatic ß-cells [6]. In the 
long-term, high blood glucose levels are toxic to 
ß-cells, leading to further deterioration in ß-cell 
function and worsening blood glucose control [7]. 
About 20 to 50 % of the people with IGT will, 
within a period of 10 years develop type 2 
diabetes, accompanied by increased risk of 
cardiovascular disease and micro vascular 
complications [8]. 
 
Elevated blood glucose levels have been shown 
to increase oxidative stresses which are known 
to induce β-cell apoptosis [9] and consequently, 
antioxidant potential of plant secondary 
metabolites. Hence, compounds with both 
antihyperglycemic and antioxidative properties 
would be useful drugs for the control of glycemia 
and evolution of type 2 diabetes and related 
cardiovascular complications. 
 
The objective of this study was to develop an 
alternative non-genetic rat model for type 2 
diabetes and to evaluate the anti-diabetic effect 
of total extract and supernatant fraction of 
Plumeria alba on this model induced by high 
fructose diet and intraperitoneal administration of 
streptozotocin. These rats form a model of 
experimental diabetes with glucose intolerance, 
hepatic oxidative stress, hyperlipidemia and high 




Plant material and extraction  
 
P. alba root were collected from the garden of 
the Teaching Hospital Sylvanus Olympio of 
Lomé, Togo. A specimen was identified by the 
Laboratory of Botany and Plant Ecology (Faculty 
of Science/University of Lomé) and retained in 
the department herbarium under number 8035. 
The roots were washed, dried under air-
conditioning and reduced to powder with electric 
mill (Thomas Scientific™, 3375-E20). 800 g of 
the powder was cold extracted in ethanol 95°/ 
water mixture (80:20) for 72 h. The crude 
extracts were filtered with Whatman paper (N° 1) 
and evaporated under vacuum at 45 °C using a 
rotary evaporator Büchi R210. The yield of the 
preparation was 11.34 %.  
 
Fractionation of hydro alcoholic extract 
 
Hydro alcoholic extract of P. alba was fractioned 
using technique of separation by precipitation in 
cold alcohol.  30 g of total extract were dissolved 
in 400 ml of 75 % alcohol. The solution was put 
in a refrigerator at 4 °C for 24 h to allow the 
precipitate settle at the bottom of the tube. The 
supernatant was separated from the clot by 
centrifugation at 2500 g and then evaporated 
under vacuum at 45 °C. The pellet from the 
supernatant was dried at ambient air. The 
fractions obtained are respectively the 
supernatant fraction (SF) and the Dregs from 
supernatant fraction (DS). 
 
Ethyl acetate fraction (EA) was obtained by 
dissolving 30 g of total extract in 5 ml of distilled 
water and then in 400 ml of ethyl acetate. The 
mixture was refrigerated at 4 °C for 24 h, treated 
as above and the supernatant was evaporated to 
give the ethyl acetate fraction (EA). 
 
These splits have allowed us to have fractions 
successively named supernatant fraction (SF) 
with a yield of 73.33 %, dregs from supernatant 
fraction (DS) yield 23.33 %, an ethyl acetate 




Male Sprague Dawley rats (body weight ranging 
from 150 to 200 g) and ICR mice (body weight 
ranging from 20 to 30 g) were provided from the 
Animal House of physiology/pharmacology 
department of the University of Lomé (Togo). 
Animals were maintained at the standard 
environmental conditions (temperature of 25 ± 2 
°C and 12/12h of light/dark cycle). They were 
given standard commercial rat chow and water 
ad libitum. Principles of laboratory animal care as 
described in the European Community guidelines 
were followed [10]. This study has the approval 





Products used for the pharmacological test were 
purchased from Sigma (St. Louis, Mo, USA, 
Richmond, CA, USA). The assay of total 
cholesterol and triglyceride were made using 
Labkit Chemelex-SA (Barcelona, Spain). 
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Oral glucose tolerance test (OGTT) in normal 
mice  
 
The effect of total extract and fractions were 
evaluated on oral glucose tolerance test using 42 
mice divided into 6 groups of seven animals 
each: Group I received distilled water (control 
group); Group II  received total extract (ET) at 
dose of 250 mg/kg; Groups III received  
supernatant fraction (SF) at dose of 100 mg/kg; 
Groups IV received ethyl acetate fraction (EA) at 
dose of 100 mg/kg body weight; Group V 
received the  dregs of supernatant fraction (DS) 
at dose of 100 mg/kg of body weight; Group VI 
received glibenclamide (GB) at the dose of 0.6 
mg/kg body weight. 
 
Thirty minutes (30 mn) later, D-glucose solution 
(2.0 g/kg) was given orally to each mouse. Pre-
prandial glucose level was measured; 30, 60, 
120 and 180 min after the glucose loading (post-
prandial glucose level) blood glucose level was 
measured with a glucometer (One Touch Ultra). 
 
Determination of anti-diabetic activity  
 
Before the administration of streptozotocin (STZ), 
rats were fed for 11 days with an enriched diet 
(Bacon-Fructose). The mixture lard-Fructose is 
prepared as follows: Fructose (6 g) was 
dissolved in 50 ml distilled water with 1.25 ml of 
tween 80 % .This solution was mixed to 50 ml of 
melted lard. After fasting for 16 h, streptozotocin 
(in a cold freshly prepared solution of 0.1 M 
citrate buffer, pH 4.5) was administered to rats by 
intraperitoneal route at 45 mg/kg on day 12 [8]. 
Animal were maintained under lard-fructose diet 
for 3 days after STZ injection and Blood glucose 
level was measured to evaluate the stability. 
Only rats with blood glucose level greater than 
200 mg/dl 72 h after administration of STZ were 





Five groups of 8 rats were established as follows: 
Group I as normal control (NC) received distilled 
water for 14 days; Group II diabetic control (DC) 
received distilled water for 14 days; Group III, IV 
and V were treated, respectively, with total 
extract (250 mg/kg), supernatant fraction (100 
mg/kg) and glibenclamide (0.6 mg/kg) for 14 
days. Blood glucose was measured every 7 days 
and body weight of animals was measured every 
two days. At the end of treatment (day 14), rats 
were anesthetized under ether and blood was 
collected by retro - orbital sinus. Blood collected 
was centrifuged at 3000 rpm for 10 minutes. 
Serum obtained was used for determination of 
blood urea, creatinine, triglycerides, total 
cholesterol and HDL cholesterol level using 
commercial kits. Low density lipoprotein (LDL) 
was calculated by using Friedewald formula 
[11].The liver was frozen during 48 h for 
evaluation of lipid peroxidation.  
 
Total hemoglobin (Hb) and glycosylated 
hemoglobin (HbA1c) assays  
 
The assay is performed by the DCA 2000 HbA1c 
system. The Ames DCA 2000 HbA1c (Bayer 
Diagnostics, Elkart, IN, USA) apparatus is a 
portable analyzer, performing a system based on 
the inhibition of agglutination of latex particles 
immunoassay. 
 
Determination of plasma GSH activity  
 
Sedlak and Lindsay [12] method was used with 
slight modification. 150 µL of Tris (0.2 M, pH = 
8.2) and 10 µL of 5, 5 '-dithiobis-2-nitrobenzoic 
acid (DTNB) (0.01 M) were added to 50 µL of 
serum or GSH. To this mixture, 790 µL of 
absolute methanol was added to reach 1 ml. All 
tubes were tightly closed and homogenized for a 
half hour. Centrifugation of all tubes was done at 
3000 rpm for 15 min at room temperature. The 
absorbance was read at 412 nm after five [5] 
minutes of incubation. 
 
Lipid peroxidation assay  
 
Solution of 1 -methyl-2-phenylindole at 10 mMis 
mixed with the iron chloride at a concentration of 
32 µM in the   proportions of 75: 25 (v/v). 
Acetonitrile was used as solvent of 1 - methyl - 2 
– phenylindole and methanol as solvent of the 
iron chloride. The liver homogenate was 
prepared grinding 0.5 g liver in 500 µL of buffer 
0.1 M Tris HCl pH 7.4. The reaction medium 
contains 650 µL of 1 -methyl -2- phenylindole 
activated 250 µL of MDA liver homogenate, 150 
µL of the HCl solution at a concentration of 12 N 
and 10 µL of the solution of BHT (butylated 
hydroxy toluene) at a concentration of 0.1 M. The 
incubation of tubes was done at 45 ° C for 1 h. 
The tubes were then centrifuged at 5000 rpm for 
10 min. The absorbance was read at the 
wavelength of 526 nm. The blank sample was 75 
% acetonitrile, 25 % of iron chloride and 200 µL 




Data are presented as mean ± SEM (n). One-
way ANOVA with Dunett’s Multiple Comparison 
post-test was performed to assess differences 
between groups (Graph PadPrism 5, San Diego, 
CA). P < 0.05 were considered statistically 
significant. 
Kadebe et al 




Effect of P. alba total extract and fractions on 
oral glucose tolerance (OGT) 
 
Figure 1 (A) shows the variation of blood glucose 
level. At T0, the average blood glucose level in 
the control like treated group was 91.16 ± 5.75 
mg/dl. Thirty minutes (30 min) after 
administration of glucose, blood glucose level in 
diabetic  control mice reached a maximum 
average value of 293 ± 17.17 mg/dl against 
197.00 ± 1.34  mg/dl , 182.71 ± 2.20 mg/dl, 
233.85 ± 4.32 mg/dl ; 271.42 ± 2.10 mg/dl and 
146.85 ± 2.60 mg/dl respectively for supernatant 
fraction (100 mg/kg), ethyl acetate fraction (100 
mg/kg), total extract (250 mg/kg), Dregs from 
supernatant fraction (100 mg/kg) and 
glibenclamide (0.6 mg/kg ) in the treated mice. 
Figure 1(B) showed that AUC of glucose during 
OGTT of diabetic group was elevated by 60 % (p 
< 0,001) when compared with normal control 
Group. The AUC of glucose tolerance test in 
treated groups (total extract, fractions and 
glibenclamide) was significantly (p < 0,001) lower 
than that of diabetic group showing improved 
glucose tolerance. This reduction was 
respectively 32.76 % (p < 0.001), 37.64 % (p < 
0.001), 20.18 % (p < 0.01) 7. 36 % (p < 0.05) and 
49.88 % (p < 0.001) of reduction. Area under the 
curve (AUC) (Fig 1 B) confirmed this reduction.  
 
Effect of P. alba total extract and supernatant 
fraction on blood glucose  
 
Table 1 shows the Levels of blood glucose in 
diabetic rats during the experiment. On day 0 
(start of treatment), blood glucose level in normal 
control rats was 99.12 ± 1.46 mg/dl against 
432.75 mg/dl in diabetic controls (Table 1). After 
two weeks of treatment, animals treated with 
total extract, supernatant fraction and 
glibenclamide showed a significant (p < 0.01) 
reduction of blood glucose level respectively 
151.50 ± 3.02 mg/dl, 127.25 ± 2.92 and 110.62 ± 
1.48 mg/dl against 268.12 mg/dl in the diabetic 
controls. 
 
Effect of P. alba total extract and supernatant 
fraction on rat body weight  
 
Table 2 shows rat body weight variation during 
the experiment. The average body weight of 
diabetic control (DC) group was 184.14 ± 1.5 g 



















































































Figure 1: Effect of P. alba total extract an fractions on 
oral glucose tolerance test in normal rats. A: Blood 
glucose level; B:area under the curve (AUC); Control: 
received distilled water ;  ET 250 mg/kg:  received 
Total extract at dose of 250 mg/kg body weight; 
received; SF100 mg / kg: supernatant fraction at dose 
of 100 mg / kg body weight;   EA100 mg/kg  received 
ethyl acetate fraction at dose of 100 mg / kg body 
weight; DS:  received the  dregs of supernatant 
fraction at dose of 100 mg / kg of body weight; GB 
received glibenclamide at the dose of 0.6 mg / kg body 
weight. Thirty minutes (30 mn) later, glucose solution 
(2.0 g/kg b.w.) was given orally to each mouse.0, 30, 
60, 120, 180 min after   glucose loading, blood glucose 
level was measured with a glucometer (One Touch 
Ultra). Values are expressed as the mean ± SEM (n = 
7). *p< 0.05;  ** p < 0,01 ; *** p < 0.001 vs control 
 
group at the start of treatment (D0). After 2 weeks 
of treatment (D14), body weight in normal control 
group was 178.25 ± 154.12 g against 154.14 ± 
1.50 g in diabetic control group. Group treated 
with total extract, supernatant fraction and 
glibenclamide showed a significant increase (p 
<0.001) of animals body weight at D14 
(respectively 165.12 ± 1.39 g, 166.00 ± 0.86 g 
and 169.14 ± 1.22 g) compared to diabetic 
control (154.42 ± 1.98 g). 
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Effect of P. alba total extract and supernatant 
fraction on rat biochemical parameters  
 
Diabetic control showed a significant increase in 
triglycerides and total cholesterol, compared to 
normal controls. The administration of P. alba 
total extract significantly reduced serum level of 
TG while increasing HDL-cholesterol level (p < 
0.01) compared to diabetic controls. 
 
The supernatant fraction (100 mg/kg/ day) and 
glibenclamide (0.6 mg /kg/day) administered 
orally reduced significantly (p < 0.01) serum level 
of TG and total cholesterol compared to diabetic 
controls. There was a significant (p < 0.01) 
increase in creatinine level (15.78 ± 0.31) and 
urea level (47.25 ± 0.85) in untreated diabetic 
rats compared respectively to normal control rats 
(10.28 ± 0.25) and (38.33 ± 0.98). Blood 
creatinine and urea level were significantly (p < 
0.01) reduced in rats treated with the total extract 
and compared to diabetic control rats (Table 3). 
 
 
Table 1: Effect of P. alba total extract supernatant fraction and glibenclamide on the evolution of blood glucose 
level during the treatment        
 
 Blood Glucose (mg/dl) 
   Dose (mg/kg) 

























NC: normal control received distilled water for 14 days; DC : diabetic control received distilled water for 14 days; 
ET250, SF100 and GB0.6 were diabetic animals treated respectively with total extract (250 mg/kg), supernatant 
fraction (100 mg/kg) and glibenclamide (0.6 mg/kg) for 14 day. Values are expressed as the mean ± SEM (n = 8). 
###p < 0.05 vs control; ***p < 0.001 vs Diabetic control 
 
Table 2: Effect of total extract and supernatant fraction obtained after centrifugation of total extract of P. alba on 
body weight 
 
 NC DC SF 100 mg/Kg ET 250 mg/Kg GB 0.6 mg/Kg 
D0       172.85±1.20 
D7       175.28±1.40 













NC: normal control received distilled water for 14 days; DC : diabetic control received distilled water for 14 days; 
ET250, SF100 and GB0.6 were diabetic animals treated respectively with total extract (250 mg / kg ), supernatant 
fraction ( 100 mg / kg ) and glibenclamide ( 0.6 mg / kg ) for 14 day. Values are expressed as the mean ± SEM (n 
= 8). ###p < 0.05 vs control; ***p < 0.001 vs Diabetic control 
 
Table 3: Effect of P. alba total extract and supernatant fraction and glibenclamide on biochemical parameters 
 
Parameter NC DC ET250 SF 100 GB 0,6 
TG (mg/dl) 29.831.90 74.174.01# # # 54.675.60* 47.006.48** 36.7020*** 
Ch (mg/dl) 59.67  3.28 68.33  3.62# # 57.95 3.20 63.6  3.40* 64.86  4.62* 
HDL-C (mg/dl) 42.50  1.67 31.20  2.2# # 49.33  4.60* 51.67 3.36** 54.56  3.09** 
LDL-C (mg/dl) 11.201.10 22.293.40## 2.311.60*** 2.531.50*** 2.961.40*** 
Urée(mg/dl) 38.33  0.98 47.250.85# # 30.33 0.98* 29.16 0.70* 27.00  0.51** 
Créat (mg/dl) 10.28  0.25 15.780.31# # 9.28  0.25** 7.80 0.19*** 8.46 0.26** 
NC: normal control received distilled water for 14 days; DC : diabetic control received distilled water for 14 days; 
ET250, SF100 and GB0.6 were diabetic animals treated respectively with total extract (250 mg/kg), supernatant 
fraction (100 mg/kg) and glibenclamide (0.6 mg/kg ) for 14 day. Values are expressed as the mean ± SEM (n = 
8). ###p < 0.05 vs control; ***p < 0.001 vs. Diabetic control 
 
Kadebe et al 
Trop J Pharm Res, January 2016; 15(1): 92  
 
Effect of P. alba total extract and supernatant 
fraction obtained after centrifugation of total 
extract on total hemoglobin and HbA1c of 
diabetic rats  
 
Total hemoglobin in normal control group was 
12.80 ± 0.40 mg/dl against 9.53 ± 0.14 mg/dl in 
diabetic control. In animals treated with   total 
extract, supernatant and glibenclamide, HbA1c 
values were respectively 10.6 5 ± 0.04 mg/dl, 
10.60 ± 0.04 mg/dl and 11 61 ± 0.26 mg/dl. 
There was a significant reduction (p < 0.01) of 
the glycated hemoglobin, to 12.33 ± 0.23 % for 
diabetic control against 10.20 ± 0.02 %, 10.84 ± 
0.08 % and 7.18 ± 0.25 % respectively for 
extract, the supernatant and glibenclamide 
treated group (Table 4). 
Effect of P. alba total extract and supernatant 
fraction on hepatic lipid peroxidation and 
serum GSH levels  
 
The concentration of MDA in diabetic control 
(1.53 ± 0.01 nM/mg) was significantly (p < 0.01) 
higher than that of normal control group (0.96 ± 
0.02 nM/mg). Administration of total extract (250 
mg/kg/day) and the supernatant (100 mg/kg) 
daily for 14 days reduced the   MDA 
concentration respectively to 1.4 ± 0.01 nM/mg 
and 1.21 ± 0.09 nM/mg (p < 0.05),. 
Administration of total extract (250 mg/kg) or 
supernatant (100 mg/kg) induce significant 
increase (p < 0.001) of GSH level in serum 
compared to untreated diabetic animals (Table 
5). 
 
Table 4: Effect of P. alba total extract supernatant fraction and glibenclamide on haemoglobin (Hb) and 
glycosylated haemoglobin (HbA1c) 
 
Parameter NC DC ET 250 SF 100 GB 0.6 
Hb (g/dl) 12.8 0±0.40 9.53 ±0.14 10.6 0± 0.04* 10.65± 0.04* 11.61± 
0.26** 
HbA1c (%Hb) 5.80 ±0.32 12.33 ±0.23## # 10.20± 0.02** 10.84 ±0.08* 7.18 ±0.25*** 
NC: normal control received distilled water for 14 days; DC : diabetic control received distilled water for 14 days; 
ET250, SF100 and GB0.6 were diabetic animals treated respectively with total extract (250 mg/kg), supernatant 
fraction (100 mg/kg) and glibenclamide (0.6 mg/kg) for 14 day. Values are expressed as the mean ± SEM (n = 8). 
###p < 0.05 vs control; ***p < 0.001 vs. Diabetic control 
 
Table 5: Effect of P. alba total extract supernatant fraction and glibenclamide on MDA and liver glutathione in 
streptozotocin-induced diabetic rats 
 
Parameter NC DC ET 250 SF100 GB 0.6 
MDA (nM/mg) 0.960.02 1.530.01## 1.40.01* 1.210.09** 0.970.01** 
GSH (µmol/mg.prot) 34.50±0.73 19.87±1.002## 26.87±0.76** 31.5±0.70*** 36.120.895*** 
NC: normal control received distilled water for 14 days; DC : diabetic control received distilled water for 14 days; 
ET250, SF100 and GB0.6 were diabetic animals treated respectively with total extract (250 mg / kg ), supernatant 
fraction ( 100 mg / kg ) and glibenclamide ( 0.6 mg / kg ) for 14 day. Values are expressed as the mean ± SEM (n 




The present study focuses on the antidiabetic 
activity of P. alba. The effect of hydroalcohol total 
extract and fractions on disturbances metabolic 
related diabetic condition such as: dyslipidemia 
dominated by hypertriglyceridemia, depressed 
HDL-cholesterol; insulin resistance characterized 
by accumulation of intra-abdominal fat and 
glucose intolerance. 
 
The hypoglycemic effect of the total extract, 
supernatant fractions (SF), ethyl acetate (EA), 
and the dregs of supernatant was evaluated on 
normal mouse hyperglycemia caused by OGTT. 
The results of this test showed that the total 
extract, supernatant and ethyl acetate fraction 
have significantly reduced hyperglycemia in 30 
min. A comparison of different fractions activities 
showed that mice treated with ethyl acetate 
fractions and supernatant fraction at a dose of 
100 mg/kg had the highest hypoglycemic effect. 
Our previous studies performed on the hydro-
alcoholic total extract showed a decrease in 
basal glucose levels in normal rats [14]. This 
indicates that hypoglycemic activity of the plant is 
mediated by increased peripheral glucose 
metabolism or by a direct or indirect stimulation 
of insulin secretion. This hypoglycemic activity 
would be comparable to that of the reference 
drug used (glibenclamide 0.6 mg/kg). It is an oral 
antidiabetic agent which acts sulfonamide 
stimulating insulin secretion by binding a specific 
receptor Sulfonyl Urea Receptor (ON) present on 
Kadebe et al 
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the membrane of pancreatic beta cells. 
Sulfonamides thus stimulate the release of 
insulin already synthesized. 
 
In this study, STZ was used to induce diabetes. It 
selectively destroys the insulin secreting 
pancreatic cells, leaving the less active cells and 
thus resulting in diabetic state [15]. STZ-induced 
diabetes is characterized by severe weight loss 
which was observed in the present study. The 
reduction in body weight may be attributed to 
insulin depletion provoking a loss of adipose 
tissues. The loss of weight in diabetic rats might 
also be the result of degradation of structural 
proteins due to unavailability of carbohydrate as 
energy source [16]. For this reason, weight 
reduction is being used as a marker of diabetes 
mellitus induced by STZ [17]. In the present 
study, supernatant fraction (SF) was chosen 
among all active fractions for STZ induced 
diabetes because of his similarity to traditional 
preparation with no toxic solvent. Then, oral 
administration of total extract and supernatant of 
P. alba to STZ-induced diabetic rats caused 
significant improvement in the body weight gain. 
This may be due to the effect of total extract and 
supernatant fraction of P. alba on glucose 
metabolism. 
 
In the present study, an increase of blood 
glucose level in diabetic rats confirmed the 
induction of diabetes by STZ. The fundamental 
mechanism underlying hyperglycemia in diabetes 
involves the overproduction of glucose by 
excessive hepatic glycogenolysis, gluconeo-
genesis and decreased utilization by the tissues 
[18].  A significant decrease of blood glucose 
level in total extract and supernatant of P. alba 
treated diabetic rats compared to diabetic control 
rats was observed. This could be due to the 
regeneration of existing pancreatic beta cells and 
enhanced transport of glucose to the peripheral 
tissues by hydro alcoholic extract and 
supernatant of P. alba. 
 
A significant decrease in the level of total 
hemoglobin and significant increase in the level 
of glycosylated hemoglobin observed in STZ 
induced diabetic rats might be due to the 
increased formation of glycosylated hemoglobin. 
Glycosylated hemoglobin was found to increase 
in uncontrolled diabetes and the increase is 
directly proportional to the fasting blood glucose 
level for about 3 months [19]. During diabetes, 
the excess glucose present in the blood reacts 
with hemoglobin to form glycosylated hemoglobin 
[20]. Therefore,   total hemoglobin level is 
decreased in diabetic rats. The rate of glycation 
is directly proportional to the concentration of 
blood glucose [20]. The level of glycosylated 
hemoglobin has been shown to provide an index 
of blood glucose concentration [22]. The 
decreased level of glycosylated hemoglobin and 
increased level of total hemoglobin observed in 
hydro alcoholic extract and supernatant of P. 
alba administered diabetic rats may be due to the 
reduction of blood glucose level. 
 
Lipid profile is of crucial importance in the 
diagnosis and treatment of several 
cardiovascular diseases and control of diabetic 
patients [23]. Studies have reported that 
cardiovascular complications associated with 
diabetes are due to disturbances of lipid 
metabolism [24]. The results of this study 
showed significant increase of lipid parameters in 
STZ induced diabetic animal such as: total 
cholesterol, TG and LDL-cholesterol, all this 
combined with a decrease in HDL-cholesterol. 
The administration of total extract and the 
supernatant fraction of P. alba led to a significant 
improvement in lipid profile. A low concentration 
of HDL-cholesterol can be regarded as an 
additional risk factor and then a high 
concentration of HDL-cholesterol is a protective 
factor. It was proposed to use the ratios (total 
cholesterol/HDL-cholesterol) or (LDL-
cholesterol/HDL-cholesterol) as an indicator of 
cardiovascular risk. Administration of total extract 
and supernatant of P. alba increased significantly 
HDL-cholesterol. P. alba is endowed with 
hypoglycemic and hypolipidemic properties and 
can therefore be used in the treatment of 
cardiovascular complications associated with 
diabetes.  
 
Chronic hyperglycemia in diabetes leads to 
oxidative stress characterized by an imbalance 
between the production of free radical species, 
peroxides and their removal by enzymatic 
antioxidant defenses and nonenzymatic cellular. 
It is reported that the production of ROS and lipid 
peroxidation are increased in diabetic patients 
and that oxidative stress is responsible for the 
pathophysiology of diabetes [23], especially, that 
associated with antioxidant treatment showed 
significant improvement and prevention against 
cardiovascular complications [25].  
 
In this study, lipid peroxidation was evaluated in 
the liver by measuring the level of MDA 
(malondialdehyde) marker of peroxidation 
regarding the evaluation of antioxidant defense 
mechanisms by the glutathione peroxidase 
(GSH) in serum. The results showed a significant 
high MDA levels in STZ diabetic animals with 
reduction of antioxidant defenses (glutathione 
decreased). Our results agree with those 
reported by some authors [9]. The increase of 
MDA rate indicates increased lipid peroxidation 
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and the degree of damage to these organs. GSH 
depletion may mean oxidation by free radicals 
oxidized GSSG. Treatment of the diabetic rats 
with P. alba extract not only reduced the 





Findings from this study reveal that the total 
extract and supernatant fraction of the total 
extract possess antidiabetic and hypolipidemic 
activities which can potentially be developed for 
the management of diabetes. The findings also 
lend credence for the use of this plant in the 
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